Single Dose and Multiple Dose Trial to Assess Pharmacokinetics of Obeticholic Acid (OCA)
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is a single center, open label, randomized, parallel design, single and multiple dose
trial to evaluate the pharmacokinetics(PK), safety and tolerability of obeticholic acid
(OCA).